218 related articles for article (PubMed ID: 24529651)
1. Redox-activated MRI contrast agents based on lanthanide and transition metal ions.
Tsitovich PB; Burns PJ; McKay AM; Morrow JR
J Inorg Biochem; 2014 Apr; 133():143-54. PubMed ID: 24529651
[TBL] [Abstract][Full Text] [Related]
2. MRI probes for sensing biologically relevant metal ions.
Bonnet CS; Tóth E
Future Med Chem; 2010 Mar; 2(3):367-84. PubMed ID: 21426172
[TBL] [Abstract][Full Text] [Related]
3. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
[TBL] [Abstract][Full Text] [Related]
4. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
[TBL] [Abstract][Full Text] [Related]
5. Lanthanides in magnetic resonance imaging.
Bottrill M; Kwok L; Long NJ
Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
[TBL] [Abstract][Full Text] [Related]
6. Smart Contrast Agents for Magnetic Resonance Imaging.
Bonnet CS; Tóth É
Chimia (Aarau); 2016; 70(1-2):102-8. PubMed ID: 26931225
[TBL] [Abstract][Full Text] [Related]
7. PARACEST agents: modulating MRI contrast via water proton exchange.
Zhang S; Merritt M; Woessner DE; Lenkinski RE; Sherry AD
Acc Chem Res; 2003 Oct; 36(10):783-90. PubMed ID: 14567712
[TBL] [Abstract][Full Text] [Related]
8. Redox- and hypoxia-responsive MRI contrast agents.
Do QN; Ratnakar JS; Kovács Z; Sherry AD
ChemMedChem; 2014 Jun; 9(6):1116-29. PubMed ID: 24825674
[TBL] [Abstract][Full Text] [Related]
9. Lanthanide chelates containing pyridine units with potential application as contrast agents in magnetic resonance imaging.
Platas-Iglesias C; Mato-Iglesias M; Djanashvili K; Muller RN; Elst LV; Peters JA; de Blas A; Rodríguez-Blas T
Chemistry; 2004 Jul; 10(14):3579-90. PubMed ID: 15252806
[TBL] [Abstract][Full Text] [Related]
10. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents.
Ferrauto G; Delli Castelli D; Di Gregorio E; Langereis S; Burdinski D; Grüll H; Terreno E; Aime S
J Am Chem Soc; 2014 Jan; 136(2):638-41. PubMed ID: 24359116
[TBL] [Abstract][Full Text] [Related]
11. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
12. Novel polycarboxylated EDTA-type cyclodextrins as ligands for lanthanide binding: study of their luminescence, relaxivity properties of Gd(iii) complexes, and PM3 theoretical calculations.
Maffeo D; Lampropoulou M; Fardis M; Lazarou YG; Mavridis IM; Mavridou DA; Urso E; Pratsinis H; Kletsas D; Yannakopoulou K
Org Biomol Chem; 2010 Apr; 8(8):1910-21. PubMed ID: 20449498
[TBL] [Abstract][Full Text] [Related]
13. A robust and convergent synthesis of dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents.
Wojciechowski F; Suchy M; Li AX; Azab HA; Bartha R; Hudson RH
Bioconjug Chem; 2007; 18(5):1625-36. PubMed ID: 17711349
[TBL] [Abstract][Full Text] [Related]
14. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
[TBL] [Abstract][Full Text] [Related]
15. Tailoring encodable lanthanide-binding tags as MRI contrast agents.
Daughtry KD; Martin LJ; Sarraju A; Imperiali B; Allen KN
Chembiochem; 2012 Nov; 13(17):2567-74. PubMed ID: 23150430
[TBL] [Abstract][Full Text] [Related]
16. Copper complexes as a source of redox active MRI contrast agents.
Dunbar L; Sowden RJ; Trotter KD; Taylor MK; Smith D; Kennedy AR; Reglinski J; Spickett CM
Biometals; 2015 Oct; 28(5):903-12. PubMed ID: 26253716
[TBL] [Abstract][Full Text] [Related]
17. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
Milne M; Chicas K; Li A; Bartha R; Hudson RH
Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
[TBL] [Abstract][Full Text] [Related]
18. Comparison of divalent transition metal ion paraCEST MRI contrast agents.
Dorazio SJ; Olatunde AO; Tsitovich PB; Morrow JR
J Biol Inorg Chem; 2014 Feb; 19(2):191-205. PubMed ID: 24253281
[TBL] [Abstract][Full Text] [Related]
19. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
20. Critical in vitro evaluation of responsive MRI contrast agents for calcium and zinc.
Mishra A; Logothetis NK; Parker D
Chemistry; 2011 Feb; 17(5):1529-37. PubMed ID: 21268155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]